期刊
FEBS LETTERS
卷 590, 期 22, 页码 4116-4125出版社
WILEY-BLACKWELL
DOI: 10.1002/1873-3468.12300
关键词
bone marrow transplantation; embryonic stem cells; hemogenic endothelium; reprogramming
资金
- Cancer Research UK [12486] Funding Source: researchfish
Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据